BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2022 10:52:23 AM | Browse: 339 | Download: 598
 |
Received |
|
2021-09-24 12:16 |
|
Peer-Review Started |
|
2021-09-24 12:18 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-08 19:44 |
|
Revised |
|
2021-11-17 11:09 |
|
Second Decision |
|
2022-03-28 05:47 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-04-04 06:33 |
|
Articles in Press |
|
2022-04-04 06:33 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-04-11 01:40 |
|
Publish the Manuscript Online |
|
2022-04-22 10:52 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ross Apostolov, Emily Gianatti, Darren Wong, Numan Kutaiba, Paul Gow, Mathis Grossmann and Marie Sinclair |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ross Apostolov, MBBS, Academic Fellow, Staff Physician, Department of Gastroenterology and Liver Transplant Unit, Austin Health, 145 Studley Road, Heidelberg 3084, VIC, Australia. ross.apostolov1@gmail.com |
| Key Words |
Hepatic steatosis; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Testosterone therapy; Testosterone undecanoate; Type 2 diabetes |
| Core Tip |
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent disease with no current effective treatment. This study demonstrates a reduction in hepatic steatosis in men with type 2 diabetes and low testosterone who received testosterone therapy as part of a randomised controlled trial and provides justification for larger scale studies to assess the effects of testosterone therapy as a treatment for NAFLD. |
| Publish Date |
2022-04-22 10:52 |
| Citation |
Apostolov R, Gianatti E, Wong D, Kutaiba N, Gow P, Grossmann M, Sinclair M. Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations. World J Hepatol 2022; 14(4): 754-765 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i4/754.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i4.754 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
